Immunization, HepB3 in New Zealand
New Zealand: Immunization, HepB3 was 89.0% in 2024. ▲ Rising
Immunization, HepB3 in New Zealand, 1992–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
The most recent figure for immunization, hepb3 in New Zealand is 89.0%, measured in 2024.
That represents a change of up 1.1% on the previous year and down 4.3% over ten years.
Over the whole period, immunization, hepb3 in New Zealand peaked at 99.0% in 1997 and was at its lowest, 67.0%, in 1992.
That places New Zealand 102nd out of 188 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 33 years of available data.
Immunization, HepB3 in New Zealand, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1992 | 67.0% | — |
| 1993 | 74.0% | +10.4% |
| 1994 | 81.0% | +9.5% |
| 1995 | 88.0% | +8.6% |
| 1996 | 94.0% | +6.8% |
| 1997 | 99.0% | +5.3% |
| 1998 | 87.0% | -12.1% |
| 1999 | 89.0% | +2.3% |
| 2000 | 90.0% | +1.1% |
| 2001 | 90.0% | +0.0% |
| 2002 | 89.0% | -1.1% |
| 2003 | 89.0% | +0.0% |
| 2004 | 88.0% | -1.1% |
| 2005 | 87.0% | -1.1% |
| 2006 | 87.0% | +0.0% |
| 2007 | 88.0% | +1.1% |
| 2008 | 90.0% | +2.3% |
| 2009 | 93.0% | +3.3% |
| 2010 | 90.0% | -3.2% |
| 2011 | 95.0% | +5.6% |
| 2012 | 93.0% | -2.1% |
| 2013 | 93.0% | +0.0% |
| 2014 | 93.0% | +0.0% |
| 2015 | 92.0% | -1.1% |
| 2016 | 92.0% | +0.0% |
| 2017 | 94.0% | +2.2% |
| 2018 | 93.0% | -1.1% |
| 2019 | 92.0% | -1.1% |
| 2020 | 92.0% | +0.0% |
| 2021 | 90.0% | -2.2% |
| 2022 | 89.0% | -1.1% |
| 2023 | 88.0% | -1.1% |
| 2024 | 89.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 84.9% | 67.0% | 99.0% | 8 |
| 2000s | 89.1% | 87.0% | 93.0% | 10 |
| 2010s | 92.7% | 90.0% | 95.0% | 10 |
| 2020s | 89.6% | 88.0% | 92.0% | 5 |
Countries ranked near New Zealand
- 102 Burundi 89.0% compare
- 102 Colombia 89.0% compare
- 102 Marshall Islands 89.0% compare
- 102 Netherlands 89.0% compare
- 102 Nicaragua 89.0% compare
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,116 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.1187 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0277 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.018 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hepb3 in New Zealand?
- Immunization, hepb3 in New Zealand was 89.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in New Zealand?
- The highest recorded value was 99.0% in 1997.
- What is the lowest immunization, hepb3 recorded in New Zealand?
- The lowest recorded value was 67.0% in 1992.
- How does New Zealand rank for immunization, hepb3?
- New Zealand ranks 102nd out of 188 countries with data for 2024.
- Is immunization, hepb3 rising or falling in New Zealand?
- Over the last ten years it is down 4.3%. The long-run trend across the full record is rising.
- Where does this New Zealand data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.